Deutsche Bank
HEPA

Deutsche Bank’s Hepion Pharmaceuticals HEPA Stock Holding History

Deutsche Bank’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7
Closed -$37K – 4529
2019
Q4 		$37K Buy
+7
New +$27.1K ﹤0.01% 4085
2019
Q3 		– Hold
0
– – – 5052
2019
Q1 		– Hold
0
– – – 5281
2018
Q4 		– Hold
0
– – – 5253
2018
Q1 		– Hold
0
– – – 5477
2017
Q4 		– Hold
0
– – – 5040
2017
Q3 		– Hold
0
– – – 4961
2017
Q2 		– Hold
0
– – – 5001
2017
Q1 		– Hold
0
– – – 4777
2016
Q4 		– Hold
0
– – – 4972
2016
Q3 		– Hold
0
– – – 4850
2016
Q2 		– Hold
0
– – – 5249
2016
Q1 		– Hold
0
– – – 5232
2015
Q4 		– Hold
0
– – – 5323
2015
Q3 		– Hold
0
– – – 4947
2015
Q2 		– Hold
0
– – – 4828
2015
Q1 		– Hold
0
– – – 4728

Other funds holding HEPA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's HEPA Position: Q1 2020 in Review

Deutsche Bank sold out of Hepion Pharmaceuticals (HEPA) in Q1 2020, closing a stake of 7 shares — an estimated $37K sold.

Deutsche Bank first reported a position in HEPA in Q4 2019 and held it in 1 quarter. The position peaked at $37K in Q4 2019. 6 funds tracked by Wall St. Rank hold HEPA as of Q1 2020.

  • Deutsche Bank reported no remaining Hepion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 7 Hepion Pharmaceuticals shares in Q1 2020, an estimated $37K.
  • Deutsche Bank first reported a position in Hepion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Deutsche Bank's Hepion Pharmaceuticals position peaked at $37K in Q4 2019.
  • 6 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.